These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 18098321)
1. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. Bellentani S; Dalle Grave R; Suppini A; Marchesini G; Hepatology; 2008 Feb; 47(2):746-54. PubMed ID: 18098321 [TBL] [Abstract][Full Text] [Related]
2. Weight loss as a treatment for nonalcoholic fatty liver disease. Clark JM J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766 [TBL] [Abstract][Full Text] [Related]
3. The effect of lifestyle changes in non-alcoholic fatty liver disease. Centis E; Marzocchi R; Di Domizio S; Ciaravella MF; Marchesini G Dig Dis; 2010; 28(1):267-73. PubMed ID: 20460922 [TBL] [Abstract][Full Text] [Related]
4. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. St George A; Bauman A; Johnston A; Farrell G; Chey T; George J J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776 [TBL] [Abstract][Full Text] [Related]
5. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease. Cortez-Pinto H; Machado M Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):217-31. PubMed ID: 19072357 [TBL] [Abstract][Full Text] [Related]
6. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473 [TBL] [Abstract][Full Text] [Related]
7. Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational study. Moscatiello S; Di Luzio R; Bugianesi E; Suppini A; Hickman IJ; Di Domizio S; Dalle Grave R; Marchesini G Obesity (Silver Spring); 2011 Apr; 19(4):763-70. PubMed ID: 20966900 [TBL] [Abstract][Full Text] [Related]
8. Review article: the treatment of fatty liver disease associated with the metabolic syndrome. Marchesini G; Natale S; Manini R; Agostini F Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():37-9. PubMed ID: 16225470 [TBL] [Abstract][Full Text] [Related]
9. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179 [TBL] [Abstract][Full Text] [Related]